We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+11.6%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$169M
AUM Growth
-$76.8M
Cap. Flow
-$93.2M
Cap. Flow %
-55.03%
Top 10 Hldgs %
46.89%
Holding
105
New
8
Increased
16
Reduced
63
Closed
15

Top Buys

Rank Stock Value
1
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$1.53M
2
LEGN icon
Legend Biotech
LEGN
+$1.34M
3
ZLAB icon
Zai Lab
ZLAB
+$1.34M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$1.18M
5
BPMC
Blueprint Medicines
BPMC
+$1.1M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$11.2M
2
UNH icon
UnitedHealth
UNH
+$7.66M
3
MRK icon
Merck
MRK
+$7.43M
4
ABBV icon
AbbVie
ABBV
+$5.44M
5
ABT icon
Abbott
ABT
+$5.14M

Sector Composition

Rank Sector Weight
1 Healthcare 99.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
51
Moderna
MRNA
$21.8B
$933K 0.55%
13,960
-8,150
-37% -$748K
COGT icon
52
Cogent Biosciences
COGT
$6.65B
$912K 0.54%
84,400
-1,200
-1% -$11.7K
GDRX icon
53
GoodRx Holdings
GDRX
$1.04B
$805K 0.48%
116,000
-149,000
-56% -$1.17M
RCKT icon
54
Rocket Pharmaceuticals
RCKT
$340M
$801K 0.47%
43,383
+30,853
+246% +$632K
OLMA icon
55
Olema Pharmaceuticals
OLMA
$1B
$788K 0.47%
65,980
-52,500
-44% -$671K
QURE icon
56
uniQure
QURE
$3.03B
$754K 0.45%
+153,000
New +$996K
ILMN icon
57
Illumina
ILMN
$31B
$749K 0.44%
5,745
-65
-1% -$8.02K
DXCM icon
58
DexCom
DXCM
$31.5B
$717K 0.42%
10,700
-21,450
-67% -$1.76M
INSM icon
59
Insmed
INSM
$21.4B
$707K 0.42%
9,681
-140
-1% -$10.3K
HUM icon
60
Humana
HUM
$43.7B
$691K 0.41%
2,181
-2,570
-54% -$915K
ENGN icon
61
enGene Therapeutics
ENGN
$120M
$622K 0.37%
+94,219
New +$701K
ONC
62
BeOne Medicines Ltd
ONC
$32.8B
$592K 0.35%
2,637
+190
+8% +$34.2K
SMMT icon
63
Summit Therapeutics
SMMT
$10.4B
$585K 0.35%
26,700
+1,700
+7% +$23.8K
ROIV icon
64
Roivant Sciences
ROIV
$24.5B
$521K 0.31%
45,127
-830
-2% -$9.45K
ITCI
65
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$470K 0.28%
6,430
-100
-2% -$7.52K
RPRX icon
66
Royalty Pharma
RPRX
$25.9B
$465K 0.27%
16,430
-220
-1% -$6.09K
BBIO icon
67
BridgeBio Pharma
BBIO
$15.7B
$384K 0.23%
15,085
-450
-3% -$11.8K
UTHR icon
68
United Therapeutics
UTHR
$25.8B
$380K 0.22%
1,060
-760
-42% -$257K
IONS icon
69
Ionis Pharmaceuticals
IONS
$8.6B
$378K 0.22%
9,440
-220
-2% -$10.2K
TARS icon
70
Tarsus Pharmaceuticals
TARS
$2.58B
$372K 0.22%
+11,300
New +$318K
MEDP icon
71
Medpace
MEDP
$16.1B
$363K 0.21%
1,086
-20
-2% -$7.6K
VERA icon
72
Vera Therapeutics
VERA
$2.3B
$328K 0.19%
7,428
-290
-4% -$11K
SWTX
73
DELISTED
SpringWorks Therapeutics
SWTX
$321K 0.19%
+10,010
New +$374K
ASND icon
74
Ascendis Pharma A/S
ASND
$16B
$320K 0.19%
2,141
-525
-20% -$70.9K
VTRS icon
75
Viatris
VTRS
$20.4B
$298K 0.18%
25,640
+3,140
+14% +$36.2K
1 2
3
4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Sectoral Asset Management held 105 positions worth $169M, down 31% from $246M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sectoral Asset Management withdrew a net $93.2M in Q3 2024, closing 15 positions and reducing 63 holdings. Its most notable exit was Elevance Health, an estimated $2.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in iShares 0-3 Month Treasury Bond ETF worth $1.53M.

  • Sectoral Asset Management's largest Q3 2024 buy was iShares 0-3 Month Treasury Bond ETF: 15,200 shares worth $1.53M.
  • Sectoral Asset Management added most to Legend Biotech in Q3 2024, an estimated $1.34M increase.
  • Sectoral Asset Management's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $11.2M.
  • Sectoral Asset Management fully exited Elevance Health in Q3 2024, selling an estimated $2.44M.
  • Sectoral Asset Management's ten largest holdings make up 47% of its $169M portfolio in Q3 2024.
  • Sectoral Asset Management opened 8 new positions and closed 15 in Q3 2024.
  • Sectoral Asset Management's portfolio value fell 31% quarter-over-quarter to $169M.

Based on Sectoral Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.